NCT04306224 A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas Status COMPLETED Phase PHASE1
NCT04271800 Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT04270266 Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT04263935 Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma Status RECRUITING Phase N/A
NCT04236063 Rehabilitation Needs of the Malaysian Haematological Cancer Survivors Status COMPLETED Phase N/A
NCT04214093 A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors Status TERMINATED Phase PHASE1
NCT04194840 Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT Status COMPLETED Phase NA
NCT04190433 Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial Status WITHDRAWN Phase PHASE2
NCT04186637 An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT04169321 Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors Status COMPLETED Phase PHASE1
NCT04167137 Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants Status TERMINATED Phase PHASE1
NCT04163575 Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL Status UNKNOWN Phase PHASE1/PHASE2
NCT04154228 Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI Status UNKNOWN Phase NA
NCT04144140 Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 Status TERMINATED Phase PHASE1